Intra-arterial calcification poses “one of the biggest challenges” for endovascular therapy

Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular Lithotripsy (IVL; Shockwave) in the treatment of calcified arteries beyond the femoropopliteal segment, in anatomies such as below the knee and the iliac arteries.

As the clinical experience and evidence base for this technology grows, Holden, one of the earliest users in the world of IVL, shares his views on the broadening applications for IVL in larger vessel beds, such as the common femoral artery and facilitating transfemoral access for large bore devices.

This video is sponsored by Shockwave Medical.

Holden, Andrew

Andrew Holden is the director of interventional radiology at Auckland Regional Public Health Service and associate professor of Radiology at Auckland University School of Medicine in Auckland, New Zealand. He has been involved in the investigation of several endovascular devices for the treatment of abdominal aortic aneurysms and peripheral arterial disease

Add comment

Editor’s Peripheral Pick

    Subscribe to receive the very best in medical videos

    /* ]]> */